[HTML][HTML] Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
M Elmowafy, MM Al-Sanea - Saudi Pharmaceutical Journal, 2021 - Elsevier
NLCs have provoked the incessant impulsion for the development of safe and valuable drug
delivery systems owing to their exceptional physicochemical and then biocompatible …
delivery systems owing to their exceptional physicochemical and then biocompatible …
[HTML][HTML] Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration
Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
D Li, M Yang, H Xu, M Zhu, Y Zhang, C Tian… - Journal of Materials …, 2022 - pubs.rsc.org
As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …
Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review
S Cunha, CP Costa, JN Moreira, JMS Lobo… - … , Biology and Medicine, 2020 - Elsevier
Abstract Quality-by-design (QbD) approach has been applied to optimize lipid-based
nanosystems formulations, including solid lipid nanoparticles (SLN), nanostructured lipid …
nanosystems formulations, including solid lipid nanoparticles (SLN), nanostructured lipid …
Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation
P Patel, M Patel - European Journal of Pharmaceutical Sciences, 2021 - Elsevier
The present research work was aimed to explore the ability of nanostructured lipid carriers
(NLCs) to improve oral bioavailability of Nintedanib esylate (NE) via lymphatic uptake. The …
(NLCs) to improve oral bioavailability of Nintedanib esylate (NE) via lymphatic uptake. The …
Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis
NV Chokshi, HN Khatri, MM Patel - Drug development and …, 2018 - Taylor & Francis
Mycobacterium tuberculosis, being the causative infectious agent, is the leading cause of
death worldwide amongst the infectious disease. The low bioavailability of rifampicin (RIF) …
death worldwide amongst the infectious disease. The low bioavailability of rifampicin (RIF) …
Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani… - Pharmaceuticals, 2023 - mdpi.com
Chronic stable angina pectoris is the primary indication for ranolazine (RZ), an anti-anginal
drug. The drug has an anti-ischemic action that is unaffected by either blood pressure or …
drug. The drug has an anti-ischemic action that is unaffected by either blood pressure or …
Enteric-coated strategies in colorectal cancer nanoparticle drug delivery system
Colorectal cancer is one of the most common cancer diseases with the increase of cases
prevalence> 5% every year. Multidrug resistance mechanisms and non-localized therapy …
prevalence> 5% every year. Multidrug resistance mechanisms and non-localized therapy …
[HTML][HTML] Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy
This study focuses on the design, characterization, and optimization of nanostructured lipid
carriers (NLCs) loaded with docetaxel for the treatment of skin cancer. Employing a …
carriers (NLCs) loaded with docetaxel for the treatment of skin cancer. Employing a …
Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity
Lung cancer is the leading cause of cancer-related deaths in both men and women
worldwide. It is the leading cancer killer in both men and women in every Ethnic Group. A …
worldwide. It is the leading cancer killer in both men and women in every Ethnic Group. A …